Company news
22nd Century Group, Inc news in 2023
22nd Century Group, Inc's news releases, calls and decks from 2023, newest first.
22nd Century Group Completes Sale of Hemp/Cannabis Franchise
December 27, 2023
22nd Century Group's Senior Lender Approves Sale of Hemp/Cannabis Franchise on Improved Terms
December 13, 2023
22nd Century Secures $3.2 Million to Date in Warrant Exchange Transaction
December 3, 2023
22nd Century Appoints Larry Firestone as Chairman and CEO
November 28, 2023
22nd Century Group Enters into Agreement to Sell Hemp/Cannabis Franchise
November 26, 2023
22nd Century Group Continues VLN® Expansion, Now Retailing in More Than 5,100 Stores
November 7, 2023
22nd Century Group (XXII) Expands Reduced Nicotine Content Tobacco IP with Latest Technology License
November 6, 2023
22nd Century Group (XXII) Reports Third Quarter 2023 Financial Results
November 5, 2023
22nd Century Group (XXII) Supports FDA Policy Advancements, Proposed Menthol Ban Now at OMB
October 25, 2023
22nd Century Announces Pricing of $5.25 Million Public Offering
October 16, 2023
22nd Century Announces Proposed Public Offering
October 15, 2023
22nd Century Group (XXII) Adds 1,200 Drug Store Locations Selling VLN® in Five States
September 11, 2023
22nd Century Group Initiates Strategic Alternatives Process for Its Tobacco Assets
September 4, 2023
22nd Century Group (XXII) Reports Second Quarter 2023 Financial Results
August 13, 2023
22nd Century Group (Nasdaq: XXII) to Announce Second Quarter 2023 Results on August 14, 2023
August 6, 2023
22nd Century Announces Executive Leadership Changes
July 23, 2023
22nd Century Group (XXII) Regains Compliance with Nasdaq Listing Standards
July 19, 2023
A Cigarette to Help Californians Smoke Less: 22nd Century Group, Inc. Launches Reduced Nicotine VLN® King Cigarettes in California, VLN Will Be Sold at #1 U.S. Convenience Store Chain and Other Responsible Retail Locations
July 16, 2023
22nd Century Group (XXII) VLN® Products Now Selling in Montana C-Stores
July 12, 2023
22nd Century Group (XXII) Announces New Agreement with Hub, Inc. to Expand Midwest Distribution
July 11, 2023
22nd Century Announces $3.0 Million Registered Direct Offering Priced Above Market
July 5, 2023
22nd Century Announces 1-for-15 Reverse Stock Split
July 2, 2023
22nd Century Group (XXII) Announces Production of VLN® Homogenized Tobacco Leaf Sheet
June 22, 2023
22nd Century Announces $5.3 Million Registered Direct Offering Priced Above Market
June 19, 2023
22nd Century Group (XXII) Launching VLN® at #1 U.S. C-Store Chain in Texas, California and Florida
June 5, 2023
22nd Century Group (XXII) Announces Participation in the LD Micro Invitational XIII
June 1, 2023
22nd Century Group (Nasdaq: XXII) Reports First Quarter 2023 Financial Results, Introduces 2023 Full Year Revenue Outlook
May 8, 2023
22nd Century Group (Nasdaq: XXII) to Announce First Quarter 2023 Results on May 9, 2023
May 2, 2023
22nd Century Group (XXII) Announces Strategic License, Manufacturing and Distribution Agreement with Old Pal
May 1, 2023
22nd Century Group Launches New Private Label Brand with Top U.S. C-Store Chain
April 17, 2023
22nd Century Group (XXII) Announces Fully Integrated, Single-Source Strategic License, Manufacturing and Distribution Agreement with Cookies
April 4, 2023
22nd Century Group (Nasdaq: XXII) Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
March 8, 2023
22nd Century Group (XXII) Secures $21 Million Debt Financing to Expand Working Capital for Growth Initiatives
March 2, 2023
22nd Century Group (Nasdaq: XXII) to Announce Fourth Quarter and Full Year 2022 Results on March 9, 2023
February 22, 2023
22nd Century Group (XXII) Accelerates Major Growing Program to Enable Implementation of New Zealand’s Reduced-Nicotine Content Tobacco Law
February 21, 2023
22nd Century Group (XXII) Acquires RX Pharmatech Ltd, Greatly Strengthening UK and EU Market Position
January 23, 2023
22nd Century Group (XXII) Announces Filing of U.S. DMF (Drug Master File) for CBD API; New Global Sales, Marketing and Distribution Agreement with Transo-Pharm for Cannabinoid APIs
January 22, 2023
22nd Century Group (XXII) Announces U.S. Distribution Partnerships with Core-Mark and Eby-Brown
January 17, 2023
Calls in 2023
Decks in 2023
- Q2 2023 Earnings Presentation
Earnings · 20 slides · Aug 14, 2023
- Q1 2023 Earnings Presentation
Earnings · 28 slides · May 9, 2023
- Q4 2022 Earnings Presentation
Earnings · 26 slides · Mar 9, 2023